Pandemic Perspectives: 20-Plus Vaccines In Development As India Tackles COVID-19 Surge
Will Exports Resume In August?
From mRNA to subunit vaccines, Indian companies have 20 COVID-19 vaccine candidates, while three have already been approved. An August nod for Biological E could not just cut down time to immunize the country's population but also allow exports to resume.
